Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,044 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.
Fukumoto K, Kodaka F, Hasegawa N, Muraoka H, Hori H, Ichihashi K, Yasuda Y, Iida H, Ohi K, Ochi S, Ide K, Hashimoto N, Usami M, Nakamura T, Komatsu H, Okada T, Nagasawa T, Furihata R, Atake K, Kido M, Kikuchi S, Yamagata H, Kishimoto T, Makinodan M, Horai T, Takeshima M, Kubota C, Asami T, Katsumoto E, Hishimoto A, Onitsuka T, Matsumoto J, Miura K, Yamada H, Yasui-Furukori N, Watanabe K, Inada K, Otsuka K, Hashimoto R. Fukumoto K, et al. Among authors: kishimoto t. Neuropsychopharmacol Rep. 2023 Mar;43(1):33-39. doi: 10.1002/npr2.12301. Epub 2022 Nov 16. Neuropsychopharmacol Rep. 2023. PMID: 36394160 Free PMC article.
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.
Kyou Y, Yasui-Furukori N, Hasegawa N, Ide K, Ichihashi K, Hashimoto N, Hori H, Shimizu Y, Imamura Y, Muraoka H, Iida H, Ohi K, Yasuda Y, Ogasawara K, Numata S, Iga JI, Tsuboi T, Ochi S, Kodaka F, Furihata R, Onitsuka T, Makinodan M, Komatsu H, Takeshima M, Kubota C, Hishimoto A, Atake K, Yamagata H, Kido M, Nagasawa T, Usami M, Kishimoto T, Kikuchi S, Matsumoto J, Miura K, Yamada H, Watanabe K, Inada K, Hahimoto R. Kyou Y, et al. Among authors: kishimoto t. Ann Gen Psychiatry. 2022 Dec 26;21(1):52. doi: 10.1186/s12991-022-00429-8. Ann Gen Psychiatry. 2022. PMID: 36567327 Free PMC article.
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project.
Hashimoto N, Yasui-Furukori N, Hasegawa N, Ishikawa S, Hori H, Iida H, Ichihashi K, Miura K, Matsumoto J, Numata S, Kodaka F, Furihata R, Ohi K, Ogasawara K, Iga JI, Muraoka H, Komatsu H, Takeshima M, Atake K, Kido M, Nakamura T, Kishimoto T, Hishimoto A, Onitsuka T, Okada T, Ochi S, Nagasawa T, Makinodan M, Yamada H, Tsuboi T, Yamada H, Inada K, Watanabe K, Hashimoto R. Hashimoto N, et al. Among authors: kishimoto t. BMC Psychiatry. 2023 Jun 28;23(1):473. doi: 10.1186/s12888-023-04908-4. BMC Psychiatry. 2023. PMID: 37380997 Free PMC article.
Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.
Aoki Y, Takaesu Y, Matsui K, Tokumasu T, Tani H, Takekita Y, Kanazawa T, Kishimoto T, Tarutani S, Hashimoto N, Takeuchi H, Mishima K, Inada K. Aoki Y, et al. Among authors: kishimoto t. Neuropsychopharmacol Rep. 2023 Sep;43(3):391-402. doi: 10.1002/npr2.12366. Epub 2023 Jul 14. Neuropsychopharmacol Rep. 2023. PMID: 37452456 Free PMC article.
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.
Hasegawa N, Yasuda Y, Yasui-Furukori N, Yamada H, Hori H, Ichihashi K, Takaesu Y, Iida H, Muraoka H, Kodaka F, Iga JI, Hashimoto N, Ogasawara K, Ohi K, Fukumoto K, Numata S, Tsuboi T, Usami M, Hishimoto A, Furihata R, Kishimoto T, Nakamura T, Katsumoto E, Ochi S, Nagasawa T, Atake K, Kubota C, Komatsu H, Yamagata H, Ide K, Takeshima M, Kido M, Kikuchi S, Okada T, Matsumoto J, Miura K, Shimazu T, Inada K, Watanabe K, Hashimoto R. Hasegawa N, et al. Among authors: kishimoto t. Psychiatry Clin Neurosci. 2023 Oct;77(10):559-568. doi: 10.1111/pcn.13578. Epub 2023 Sep 8. Psychiatry Clin Neurosci. 2023. PMID: 37684711 Free PMC article.
Live two-way video versus face-to-face treatment for depression, anxiety, and obsessive-compulsive disorder: A 24-week randomized controlled trial.
Kishimoto T, Kinoshita S, Kitazawa M, Hishimoto A, Asami T, Suda A, Bun S, Kikuchi T, Sado M, Takamiya A, Mimura M, Sato Y, Takemura R, Nagashima K, Nakamae T, Abe Y, Kanazawa T, Kawabata Y, Tomita H, Abe K, Hongo S, Kimura H, Sato A, Kida H, Sakuma K, Funayama M, Sugiyama N, Hino K, Amagai T, Takamiya M, Kodama H, Goto K, Fujiwara S, Kaiya H, Nagao K; J‐PROTECT collaborators. Kishimoto T, et al. Psychiatry Clin Neurosci. 2024 Apr;78(4):220-228. doi: 10.1111/pcn.13618. Epub 2023 Dec 15. Psychiatry Clin Neurosci. 2024. PMID: 38102849 Clinical Trial.
Feasibility of remote interviews in assessing disease severity in patients with major depressive disorder: A pilot study.
Sumiyoshi T, Morio Y, Kawashima T, Tachimori H, Hongo S, Kishimoto T, Watanabe K, Otsubo T, Oi H, Nakagome K, Ishigooka J. Sumiyoshi T, et al. Among authors: kishimoto t. Neuropsychopharmacol Rep. 2024 Mar;44(1):149-157. doi: 10.1002/npr2.12411. Epub 2024 Jan 24. Neuropsychopharmacol Rep. 2024. PMID: 38267023 Free PMC article. Clinical Trial.
3,044 results